Dashboard
Manage Tickers

BLRX BioLineRx Ltd.

Nasdaq biolinerx.com


$ 3.51 $ -0.01 (-0.28 %)    

Thursday, 30-Oct-2025 14:15:25 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 629.19 $ -2.83 (-0.45 %)
DIA $ 476.95 $ 2.83 (0.6 %)
SPY $ 682.89 $ -0.95 (-0.14 %)
TLT $ 90.46 $ 0.06 (0.07 %)
GLD $ 368.67 $ 3.58 (0.98 %)
$ 3.5
$ 3.70
$ 3.51 x 5
$ 3.64 x 100
$ 3.53 - $ 3.70
$ 2.30 - $ 22.60
28,437
na
520.94M
$ 1.43
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

biolinerx-and-hemispherian-establish-jv-to-develop-glix1-oral-small-molecule-targeting-dna-damage-response-in-glioblastoma-and-other-cancers
BioLineRx And Hemispherian Establish JV To...
09/29/2025 11:13:00

- GLIX1 restores TET2 activity in cancer, resulting in double stranded DNA breaks in cancer cells only -- FDA IND clearance rec...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
09/16/2025 21:06:11

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
09/10/2025 21:06:05

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/19/2025 21:06:03

update-bioline-rx-q2-epads-100-beats-120-estimate-sales-304000k-miss-924000k-estimate
UPDATE: BioLine Rx Q2 EPADS $(1.00) Beats ...
08/14/2025 14:12:20

BioLine Rx (NASDAQ:BLRX) reported quarterly losses of $(1.00) per share which beat the analyst consensus estimate of $(1.20) by...

biolinerx-had-cash-cash-equivalents-and-short-term-bank-deposits-of-282m-sufficient-to-fund-operations-as-currently-planned-into-1h-of-2027
BioLineRx Had Cash, Cash Equivalents, And ...
08/14/2025 11:03:18

Core News & Articles
Earnings Scheduled For August 14, 2025
08/14/2025 08:32:32

examining-the-future-bioline-rxs-earnings-outlook
Examining the Future: BioLine Rx's Earning...
08/13/2025 16:02:30

where-bioline-rx-stands-with-analysts
Where BioLine Rx Stands With Analysts
06/17/2025 12:00:52

hc-wainwright--co-reiterates-buy-on-bioline-rx-maintains-26-price-target
HC Wainwright & Co. Reiterates Buy on BioL...
06/17/2025 11:19:06

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioLine Rx (NASDAQ:BLRX) with a Buy and maintains $26 price target.

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
06/09/2025 12:08:42

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
06/02/2025 17:06:00

dow-edges-higher-dell-shares-fall-after-q1-results
Dow Edges Higher; Dell Shares Fall After Q...
05/30/2025 18:55:53

why-is-nano-cap-biolinerx-stock-surging-on-friday
Why Is Nano-Cap BioLineRx Stock Surging On...
05/30/2025 17:58:03

BioLineRx shares new data from its Phase 2 pancreatic cancer trial, showing strong response rates and durable outcomes with mot...

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
05/30/2025 17:06:00

nasdaq-down-100-points-chicago-pmi-dips-in-may
Nasdaq Down 100 Points; Chicago PMI Dips I...
05/30/2025 15:47:37

jones-trading-upgrades-bioline-rx-to-buy-announces-12-price-target
Jones Trading Upgrades BioLine Rx to Buy, ...
05/30/2025 13:17:39

Jones Trading analyst Justin Walsh upgrades BioLine Rx (NASDAQ:BLRX) from Hold to Buy and announces $12 price target.

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
05/30/2025 12:08:22

why-uipath-shares-are-trading-higher-by-over-13-here-are-20-stocks-moving-premarket
Why UiPath Shares Are Trading Higher By Ov...
05/30/2025 11:59:47

Core News & Articles
Market-Moving News for May 30th
05/30/2025 11:15:32

REGN: -13% | Regeneron shares are trading lower after the company and Sanofi said the AERIFY-1 study met its primary endpoint b...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION